Recalls published in April 2026
Everything the FDA, USDA FSIS, CPSC and NHTSA announced in April 2026, newest first.
-
Class II · 6 months ago
Owen Biosciences Inc. HydroPeptide Clear Alliance Serum, 2.5% Benzoyl Peroxide recall: Chemical contamination: Presence of benzene
Chemical contamination: Presence of benzene
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Huons Co., Ltd. Lidocaine HCl injection, USP, 1% 50mg/5mL , 5 mL Single Dose Vials recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class III · 6 months ago
Avantor Performance Materials LLC Magnesium Chloride, 6-Hydrate, Crystal recall: Subpotent drug
Subpotent drug
-
Class II · 6 months ago
Huons Co., Ltd. Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
-
Class III · 6 months ago
Island Kinetics, Inc. d.b.a. CoValence Laboratories Skin Rehab recall: Subpotent Drug
Subpotent Drug
-
Class II · 6 months ago
Huons Co., Ltd. 0.9% Sodium Chloride Injection, USP, 10 mL Ampules recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. caring mill recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Owen Biosciences Inc. Slmd Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5% recall: Chemical contamination: Presence of benzene
Chemical contamination: Presence of benzene
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. exchange select recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
The Harvard Drug Group LLC Memantine Hydrochloride Extended-Release, Capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Sun Pharmaceutical Industries Inc Fluocinonide, USP, 0.05% Cream, 15g tube recall: Failed Viscosity Specifications: Out of Specification results
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. Discount Drug Mart Food Market recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Nephron SC, LLC Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL recall: Labelling: Illegible label
Labelling: Illegible label
-
Class II · 6 months ago
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. QC Quality Choice recall: This recall is being initiated following FDA's recommendation based
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
-
Class II · 6 months ago
Sun Pharmaceutical Industries Inc Fluocinonide, USP, 0.05% Cream, 60g tube recall: Failed Viscosity Specifications: Out of Specification results
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class III · 6 months ago
Island Kinetics, Inc. d.b.a. CoValence Laboratories Essential Calming Skin Gel recall: Subpotent Drug
Subpotent Drug
-
Class II · 6 months ago
Owen Biosciences Inc. SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide recall: Chemical contamination: Presence of benzene
Chemical contamination: Presence of benzene